In record-set­ting set­tle­ment, No­var­tis’ San­doz unit ad­mits guilt in con­spir­a­cy to fix prices

Be­com­ing the largest drug­mak­er to plead guilty in a wide-rang­ing Jus­tice De­part­ment gener­ics probe, No­var­tis ad­mit­ted to price-fix­ing charges and agreed to a record-set­ting set­tle­ment …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER